SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,264.51 330.92
( 0.43%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2311355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.8

4102.06

EPS(TTM)

Face Value()

Div & Yield %

7.33

0.02

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	940.48	819.81	806.67	690.62	779.16	487.70
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	940.48	819.81	806.67	690.62	779.16	487.70
Other Income	2.58	3.62	2.18	2.57	3.10	3.73
Stock Adjustments	68.95	24.91	-0.57	33.39	19.39	-14.29
Total Income	1012.01	848.34	808.28	726.58	801.65	477.14
EXPENDITURE :
Raw Materials	490.15	399.62	389.32	365.21	431.35	236.00
Power & Fuel Cost	32.34	18.46	17.61	15.24	11.00	9.94
Employee Cost	151.68	127.19	109.67	86.73	85.61	66.22
Other Manufacturing Expenses	45.53	29.25	28.43	24.67	27.42	18.20
Selling & Administrative Expenses	129.36	121.79	105.28	87.63	77.97	45.93
Miscellaneous Expenses	10.02	12.03	8.48	9.88	17.16	13.20
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	859.08	708.33	658.79	589.36	650.51	389.49
Operating Profit	152.93	140.01	149.48	137.22	151.14	87.65
Interest	36.61	24.52	16.79	8.22	5.37	13.63
Gross Profit	116.32	115.49	132.69	129.00	145.77	74.02
Depreciation	30.83	21.06	17.02	22.28	18.93	16.31
Profit Before Tax	85.49	94.43	115.67	106.72	126.84	57.71
Tax	13.70	18.74	26.37	28.21	32.15	17.20
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	8.63	5.75	3.17	-1.19	-1.15	-3.72
Reported Net Profit	63.15	69.93	86.14	79.70	95.84	44.23
Extraordinary Items	0.00	0.15	-1.67	0.02	0.05	0.02
Adjusted Net Profit	63.15	69.78	87.81	79.68	95.79	44.21
Adjustment below Net Profit	0.10	-0.10	0.00	0.00	0.00	0.26
P & L Balance brought forward	421.28	352.46	267.29	188.55	93.68	49.58
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.00	1.00	0.97	0.97	0.97	0.39
P & L Balance carried down	483.53	421.28	352.46	267.29	188.55	93.68
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	10.00	10.00	10.00	10.00
Dividend Per Share(Rs)	0.10	0.10	0.10	0.10	0.10	0.10
Earnings Per Share-Unit Curr	6.30	6.97	8.59	8.22	9.89	4.56
Earnings Per Share(Adj)-Unit Curr	6.30	6.97	8.59	8.22	9.89	4.56
Book Value-Unit Curr	66.23	59.96	53.11	35.88	27.76	17.89
Book Value(Adj)-Unit Curr	66.23	59.96	53.11	35.88	27.76	17.89

77,264.51 330.92 ( 0.43%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,369.62 237.64 (0.36%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)